KAUIX
Price
$6.55
Change
+$0.01 (+0.15%)
Updated
Sep 18 closing price
Net Assets
4.82B
RPTIX
Price
$97.75
Change
-$0.02 (-0.02%)
Updated
Sep 18 closing price
Net Assets
20.82B
Interact to see
Advertisement

KAUIX vs RPTIX

KAUIX vs RPTIX Comparison Chart in %
View a ticker or compare two or three
VS
KAUIX vs. RPTIX commentary
Sep 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KAUIX is a Hold and RPTIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 20.8B vs. KAUIX (4.82B). RPTIX pays higher dividends than KAUIX: RPTIX (0.11) vs KAUIX (0.00). KAUIX was incepted earlier than RPTIX: KAUIX (10 years) vs RPTIX (11 years). KAUIX (1.46) is less costly to investors than RPTIX (0.63). RPTIX is a more actively managed with annual turnover of: 31.50 vs. KAUIX (28.00). RPTIX has a lower initial minimum investment than KAUIX: RPTIX (500000) vs KAUIX (1000000). KAUIX annual gain was more profitable for investors over the last year : -1.80 vs. RPTIX (-5.48). KAUIX return over 5 years is better than : -18.94 vs. RPTIX (-23.75).
KAUIXRPTIXKAUIX / RPTIX
Total Expense Ratio1.460.63232%
Annual Report Gross Expense Ratio1.460.63232%
Fund Existence10 years11 years-
Gain YTD9.5320.1645,814%
Front LoadN/AN/A-
Min. Initial Investment1000000500000200%
Min. Initial Investment IRAN/AN/A-
Net Assets4.82B20.8B23%
Annual Yield % from dividends0.000.11-
Returns for 1 year-1.80-5.4833%
Returns for 3 years26.940.289,510%
Returns for 5 years-18.94-23.7580%
Returns for 10 yearsN/A28.96-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ITYRX74.290.53
+0.72%
Invesco Technology R
GGQPX21.700.02
+0.09%
Goldman Sachs Mid Cap Growth P
FGDHX43.410.04
+0.09%
Fidelity Advisor® Dividend Growth I
SEMCX30.46-0.14
-0.46%
SEI Mid-Cap F (SIMT)
BRSSX16.50-0.08
-0.48%
MFS Blended Research Small Cap Eq R2